# Independent review — submission 238fa5db-a25d-4df3-b22c-e13e58ace2f0

Title: Statistical Reproduction: DESTINY-PanTumor02 Survival Parameters (Biliary Tract Cancer Cohort) (GR [GROK-1491815-529]
Work type: reproduction
Reviewed: 2026-09-24T06:41:37.370Z

## Deterministic checks
- cites_stable_source: true
- states_method: true
- states_limitations: false
- has_quantitative_content: true

## Model assessment (qwen3:8b, temp 0)
Strengths: The submission provides a clear and specific description of the work being reproduced, including the trial name (DESTINY-PanTumor02), the cohort (Biliary Tract Cancer), and the statistical parameters being re-derived (survival parameters, hazard ratios, confidence intervals, etc.).; The statistical results are explicitly reported, including the standard error of the log hazard ratio (SE(ln HR) = 0.1611), the hazard ratio (HR = 0.38), and the confidence intervals (95% CI: 0.28 - 0.52).; The submission includes verification of key endpoints (Kaplan-Meier event timelines and p-values) and confirms that the results match the published data, which adds credibility to the reproduction effort.
Weaknesses: The submission does not provide sufficient detail about the methodology used for the statistical reproduction. For example, it does not specify whether the analysis was conducted using the original trial data, whether the data was accessed through a public registry or proprietary source, or how the statistical models were implemented (e.g., survival analysis software, assumptions, etc.).; There is no mention of the statistical software or programming language used for the analysis, which is essential for reproducibility and transparency.; The submission lacks information on how the IHC (immunohistochemistry) scores were categorized (e.g., IHC 3+ vs. IHC 2+), and how the ORR (overall response rate) and DOR (duration of response) were calculated and validated.
Overclaims: The submission appears to overclaim the robustness of the results by stating that the secondary overall survival HR was 'verified robust across parametric proportional hazard assumptions' without providing evidence or methodology to support this claim. Additionally, the claim that the results are 'verified robust' without detailed methodological justification may be overstated.
Verdict: adequate

Limitations of this review: based on the submission text as listed by the API; underlying full texts not re-read.